+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
18F-FDG Market - Global Forecast 2026-2032- Product Image
18F-FDG Market - Global Forecast 2026-2032- Product Image
Sale

18F-FDG Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6279464
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

18F-FDG: Executive Summary and Market Context

18F-FDG is a radiolabeled glucose analogue used primarily with positron emission tomography (PET) to visualize elevated cellular glucose metabolism. Its established clinical role spans oncology, neurology, and selected cardiology applications. Use is shaped by clinical guidelines, PET/CT and PET/MRI availability, radiopharmacy capabilities, reimbursement, regulatory requirements, and the need for reliable short-lived-radionuclide logistics.

Clinical Integration and Operational Shifts Shaping 18F-FDG Use

The landscape is shifting toward more standardized PET protocols, quantitative image assessment, hybrid imaging, and multidisciplinary interpretation. In oncology, 18F-FDG PET increasingly complements anatomical imaging for staging, treatment response assessment, and recurrence evaluation where clinically appropriate. Operational priorities include production quality, dose calibration, cold-chain timing, radiation safety, scheduling efficiency, and protocol harmonization across institutions. These changes favor providers that can connect radiopharmacy, imaging, reporting, and follow-up data within a coordinated care pathway.

How Artificial Intelligence Is Changing 18F-FDG Imaging Workflows

Artificial intelligence is being applied to image reconstruction, denoising, attenuation correction, lesion detection, segmentation, radiomic feature extraction, and workflow prioritization. In 18F-FDG PET, these tools may support consistent assessment of metabolic activity and reduce repetitive tasks, but their clinical value depends on representative validation data, transparent performance measures, interoperability, and human oversight. Implementation should address false positives, false negatives, dataset shift, cybersecurity, privacy, and regulatory clearance rather than treating algorithmic output as a substitute for specialist interpretation.

Regional Insights: Infrastructure, Access, and Clinical Adoption Patterns

North America combines extensive PET infrastructure, established radiopharmacy networks, and substantial clinical research activity, while access remains influenced by reimbursement and geographic concentration. Europe benefits from mature nuclear medicine practice and coordinated clinical standards, although regulatory and health-system differences affect implementation. Asia-Pacific shows strong growth in imaging capacity and radiopharmaceutical capability alongside uneven access between major urban centers and other areas. Latin America is expanding specialized imaging services but continues to face constraints involving equipment, trained personnel, reimbursement, and radionuclide logistics. The Middle East is developing advanced hospital and diagnostic infrastructure, with adoption often concentrated in major medical hubs. Africa has pockets of specialized PET capability, while broader access is limited by capital requirements, supply-chain complexity, workforce shortages, and referral distances.

Group Insights: Policy and Cooperation Shape 18F-FDG Access

ASEAN countries exhibit varied PET availability and regulatory environments, making regional training, referral coordination, and harmonized quality practices important. BRICS members span highly developed and emerging imaging systems, with domestic production, infrastructure, and affordability differing substantially. The European Union benefits from cross-border scientific collaboration and shared regulatory frameworks, though national reimbursement and service organization remain distinct. G7 systems generally possess advanced imaging and research capabilities but continue to address workforce, cost, and equitable-access challenges. GCC countries are investing in specialized healthcare infrastructure and centralized expertise, while logistics and workforce localization remain relevant considerations. NATO members encompass diverse health systems, making interoperability, emergency preparedness, and resilient medical supply chains useful areas of cooperation.

Country Insights: Diverse National Conditions for 18F-FDG Deployment

Australia’s dispersed population makes hub-and-spoke distribution and coordinated referral pathways important. Brazil combines sophisticated centers with substantial regional variation in access and logistics. Canada’s geography reinforces the importance of centralized production, transport reliability, and equitable provincial provision. China has expanded advanced imaging and radiopharmacy capabilities, with regulatory and regional implementation differences. France, Germany, Italy, and Spain have established nuclear medicine sectors, but reimbursement, procurement, and regional organization vary across and within these countries. India’s demand is concentrated around major urban and tertiary-care centers, alongside opportunities to strengthen access and quality systems. Japan and South Korea have advanced imaging ecosystems supported by specialized clinical expertise and technology adoption. Mexico continues to develop PET access while addressing regional disparities and supply logistics. Russia’s capacity and access are shaped by national infrastructure, geography, and availability of specialized production and services. The United Kingdom maintains established PET practice, with commissioning, service capacity, and health-system priorities influencing availability. The United States has broad clinical and research adoption, with access affected by reimbursement, provider distribution, regulatory compliance, and radiopharmacy operations.

Priority Actions for Leaders in 18F-FDG Imaging and Radiopharmacy

Industry leaders should strengthen end-to-end reliability by mapping isotope production, dispensing, transport, scheduling, administration, imaging, and reporting as one time-sensitive workflow. They should standardize protocols and quality controls, invest in qualified personnel, and use interoperable systems that connect PET data with clinical records and treatment pathways. AI programs should begin with clearly defined clinical problems, independent validation, monitoring for bias and drift, and accountable clinician review. Leaders should also develop resilient supplier and distribution arrangements, collaborate with regulators and payers on evidence-based access, and design regional service models that reduce travel burdens without compromising safety or diagnostic quality.

Research Methodology for the 18F-FDG Executive Summary

This summary uses a qualitative synthesis of established clinical, operational, regulatory, and technology considerations associated with 18F-FDG PET. The assessment organizes findings across required regions, economic and policy groups, and countries, focusing on documented patterns in healthcare infrastructure, radiopharmacy operations, clinical adoption, access, and AI-enabled imaging. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific analysis. Interpretations should be validated against current national regulations, clinical guidelines, reimbursement policies, facility-level capabilities, and local supply conditions before operational decisions are made.

Conclusion: Building Reliable, Equitable, and Clinically Governed 18F-FDG Services

18F-FDG remains an important tool for metabolic imaging, supported by established clinical applications and a broad international evidence base. Future performance will depend less on the tracer alone than on coordinated radiopharmacy, imaging infrastructure, specialist expertise, data governance, reimbursement, and equitable access. Providers and policymakers that combine operational resilience with rigorous clinical standards and responsible AI oversight will be better positioned to improve consistency, patient pathways, and diagnostic value across diverse health systems.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. 18F-FDG Market, by Product Type
7.1. Introduction
7.2. Diagnostic Radiopharmaceutical
7.3. Research Grade
7.3.1. Clinical Trial Supply
7.3.2. Preclinical
8. 18F-FDG Market, by Formulation
8.1. Introduction
8.2. Kit-Based Preparation
8.3. Sterile Aqueous Solution
8.3.1. Pre-Filled Syringe
8.3.2. Single-Dose Vial
9. 18F-FDG Market, by Synthesis Process
9.1. Introduction
9.2. Electrophilic Methods
9.3. Kit-Based Synthesis
9.4. Nucleophilic Fluorination
9.4.1. Automated Synthesis
9.4.2. Manual Synthesis
10. 18F-FDG Market, by Application
10.1. Introduction
10.2. Cardiology
10.2.1. Inflammation Imaging
10.2.2. Myocardial Viability
10.3. Infection And Inflammation
10.4. Neurology
10.4.1. Dementia
10.4.2. Epilepsy
10.4.3. Neurodegenerative Disorders
10.5. Oncology
10.5.1. Hematologic Malignancies
10.5.2. Solid Tumors
10.5.2.1. Breast Cancer
10.5.2.2. Colorectal Cancer
10.5.2.3. Lung Cancer
11. 18F-FDG Market, by End User
11.1. Introduction
11.2. Ambulatory Imaging Centers
11.3. Contract Research Organizations
11.4. Hospitals
11.4.1. Hospital Outpatient Departments
11.4.2. Imaging Centers Within Hospitals
11.5. Pharmaceutical Companies
11.6. Research Institutions
12. 18F-FDG Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. 18F-FDG Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. 18F-FDG Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Advanced Accelerator Applications S.A.
16.2. Blue Earth Diagnostics Ltd.
16.3. Cardinal Health, Inc.
16.4. China Isotope & Radiation Corporation
16.5. Curium Pharma
16.6. DuChemBio Co., Ltd.
16.7. Eckert & Ziegler AG
16.8. GE HealthCare Technologies Inc.
16.9. Jubilant Pharmova Limited
16.10. Lantheus Holdings, Inc.
16.11. Life Molecular Imaging
16.12. Nihon Medi-Physics Co., Ltd.
16.13. PETNET Solutions, Inc.
16.14. PharmaLogic Holdings Corp.
16.15. Siemens Healthineers AG
16.16. Yantai Dongcheng Pharmaceutical Group Co., Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global 18F-FDG Market, Years Considered for the Study
FIGURE 2. Global 18F-FDG Market, Research Design
FIGURE 3. Global 18F-FDG Market, Research Framework
FIGURE 4. Global 18F-FDG Market, Data Triangulation
FIGURE 5. Global 18F-FDG Market Size, 2017-2032 (USD Million)
FIGURE 6. Global 18F-FDG Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global 18F-FDG Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global 18F-FDG Market Size, by Formulation, 2025 vs 2032 (%)
FIGURE 9. Global 18F-FDG Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global 18F-FDG Market Size, by Synthesis Process, 2025 vs 2032 (%)
FIGURE 11. Global 18F-FDG Market Size, by Synthesis Process, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global 18F-FDG Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global 18F-FDG Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global 18F-FDG Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global 18F-FDG Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global 18F-FDG Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global 18F-FDG Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global 18F-FDG Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global 18F-FDG Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global 18F-FDG Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global 18F-FDG Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global 18F-FDG Market Segmentation & Coverage
TABLE 2. Global 18F-FDG Market Size, 2017-2032 (USD Million)
TABLE 3. Global 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Diagnostic Radiopharmaceutical Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Diagnostic Radiopharmaceutical Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Diagnostic Radiopharmaceutical Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Research Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Research Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Research Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Clinical Trial Supply Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Clinical Trial Supply Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Clinical Trial Supply Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Preclinical Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Preclinical Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Preclinical Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 17. Global Kit-Based Preparation Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Kit-Based Preparation Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Kit-Based Preparation Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Sterile Aqueous Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Sterile Aqueous Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Sterile Aqueous Solution Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Pre-Filled Syringe Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Pre-Filled Syringe Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Pre-Filled Syringe Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Single-Dose Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Single-Dose Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Single-Dose Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 30. Global Electrophilic Methods Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Electrophilic Methods Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Electrophilic Methods Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Kit-Based Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Kit-Based Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Kit-Based Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Nucleophilic Fluorination Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Nucleophilic Fluorination Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Nucleophilic Fluorination Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Automated Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Automated Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Automated Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Manual Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Manual Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Manual Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 46. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Inflammation Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Inflammation Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Inflammation Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Myocardial Viability Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Myocardial Viability Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Myocardial Viability Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Infection And Inflammation Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Infection And Inflammation Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Infection And Inflammation Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Dementia Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Dementia Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Dementia Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Epilepsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Epilepsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Epilepsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Neurodegenerative Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Neurodegenerative Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Neurodegenerative Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Hematologic Malignancies Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Hematologic Malignancies Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Hematologic Malignancies Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Solid Tumors Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Solid Tumors Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Solid Tumors Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Breast Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Breast Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Breast Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Colorectal Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Colorectal Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Colorectal Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Lung Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Lung Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Lung Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 89. Global Ambulatory Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Ambulatory Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Ambulatory Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Hospital Outpatient Departments Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Hospital Outpatient Departments Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Hospital Outpatient Departments Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Imaging Centers Within Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Imaging Centers Within Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Imaging Centers Within Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Research Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Research Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Research Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global 18F-FDG Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific 18F-FDG Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific 18F-FDG Market Size, by Nucleophilic Fluorination, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific 18F-FDG Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific 18F-FDG Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific 18F-FDG Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific 18F-FDG Market Size, by Solid Tumors, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific 18F-FDG Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 125. North America 18F-FDG Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. North America 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. North America 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 128. North America 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 129. North America 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-2032 (USD Million)
TABLE 130. North America 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 131. North America 18F-FDG Market Size, by Nucleophilic Fluorination, 2017-2032 (USD Million)
TABLE 132. North America 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 133. North America 18F-FDG Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 134. North America 18F-FDG Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 135. North America 18F-FDG Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 136. North America 18F-FDG Market Size, by Solid Tumors, 2017-2032 (USD Million)
TABLE 137. North America 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. North America 18F-FDG Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 139. Latin America 18F-FDG Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Latin America 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 141. Latin America 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 142. Latin America 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 143. Latin America 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-2032 (USD Million)
TABLE 144. Latin America 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 145. Latin America 18F-FDG Market Size, by Nucleophilic Fluorination, 2017-2032 (USD Million)
TABLE 146. Latin America 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 147. Latin America 18F-FDG Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 148. Latin America 18F-FDG Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 149. Latin America 18F-FDG Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 150. Latin America 18F-FDG Market Size, by Solid Tumors, 2017-2032 (USD Million)
TABLE 151. Latin America 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. Latin America 18F-FDG Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 153. Europe 18F-FDG Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Europe 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 155. Europe 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 156. Europe 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 157. Europe 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-2032 (USD Million)
TABLE 158. Europe 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 159. Europe 18F-FDG Market Size, by Nucleophilic Fluorination, 2017-2032 (USD Million)
TABLE 160. Europe 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. Europe 18F-FDG Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 162. Europe 18F-FDG Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 163. Europe 18F-FDG Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 164. Europe 18F-FDG Market Size, by Solid Tumors, 2017-2032 (USD Million)
TABLE 165. Europe 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. Europe 18F-FDG Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 167. Middle East 18F-FDG Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Middle East 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 169. Middle East 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 170. Middle East 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 171. Middle East 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-2032 (USD Million)
TABLE 172. Middle East 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 173. Middle East 18F-FDG Market Size, by Nucleophilic Fluorination, 2017-2032 (USD Million)
TABLE 174. Middle East 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. Middle East 18F-FDG Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 176. Middle East 18F-FDG Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 177. Middle East 18F-FDG Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 178. Middle East 18F-FDG Market Size, by Solid Tumors, 2017-2032 (USD Million)
TABLE 179. Middle East 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 180. Middle East 18F-FDG Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 181. Africa 18F-FDG Market Size, by Region, 2017-2032 (USD Million)
TABLE 182. Africa 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. Africa 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 184. Africa 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 185. Africa 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-2032 (USD Million)
TABLE 186. Africa 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 187. Africa 18F-FDG Market Size, by Nucleophilic Fluorination, 2017-2032 (USD Million)
TABLE 188. Africa 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. Africa 18F-FDG Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 190. Africa 18F-FDG Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 191. Africa 18F-FDG Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 192. Africa 18F-FDG Market Size, by Solid Tumors, 2017-2032 (USD Million)
TABLE 193. Africa 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. Africa 18F-FDG Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 195. Global 18F-FDG Market Size, by Group, 2017-2032 (USD Million)
TABLE 196. ASEAN 18F-FDG Market Size, by Group, 2017-2032 (USD Million)
TABLE 197. ASEAN 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 198. ASEAN 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 199. ASEAN 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 200. ASEAN 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-2032 (USD Million)
TABLE 201. ASEAN 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 202. ASEAN 18F-FDG Market Size, by Nucleophilic Fluorination, 2017-2032 (USD Million)
TABLE 203. ASEAN 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. ASEAN 18F-FDG Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 205. ASEAN 18F-FDG Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 206. ASEAN 18F-FDG Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 207. ASEAN 18F-FDG Market Size, by Solid Tumors, 2017-2032 (USD Million)
TABLE 208. ASEAN 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. ASEAN 18F-FDG Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 210. GCC 18F-FDG Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. GCC 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 212. GCC 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 213. GCC 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 214. GCC 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-2032 (USD Million)
TABLE 215. GCC 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 216. GCC 18F-FDG Market Size, by Nucleophilic Fluorination, 2017-2032 (USD Million)
TABLE 217. GCC 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 218. GCC 18F-FDG Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 219. GCC 18F-FDG Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 220. GCC 18F-FDG Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 221. GCC 18F-FDG Market Size, by Solid Tumors, 2017-2032 (USD Million)
TABLE 222. GCC 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. GCC 18F-FDG Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 224. European Union 18F-FDG Market Size, by Group, 2017-2032 (USD Million)
TABLE 225. European Union 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 226. European Union 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 227. European Union 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 228. European Union 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-2032 (USD Million)
TABLE 229. European Union 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 230. European Union 18F-FDG Market Size, by Nucleophilic Fluorination, 2017-2032 (USD Million)
TABLE 231. European Union 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 232. European Union 18F-FDG Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 233. European Union 18F-FDG Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 234. European Union 18F-FDG Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 235. European Union 18F-FDG Market Size, by Solid Tumors, 2017-2032 (USD Million)
TABLE 236. European Union 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. European Union 18F-FDG Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 238. BRICS 18F-FDG Market Size, by Group, 2017-2032 (USD Million)
TABLE 239. BRICS 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 240. BRICS 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 241. BRICS 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 242. BRICS 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-2032 (USD Million)
TABLE 243. BRICS 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 244. BRICS 18F-FDG Market Size, by Nucleophilic Fluorination, 2017-2032 (USD Million)
TABLE 245. BRICS 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 246. BRICS 18F-FDG Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 247. BRICS 18F-FDG Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 248. BRICS 18F-FDG Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 249. BRICS 18F-FDG Market Size, by Solid Tumors, 2017-2032 (USD Million)
TABLE 250. BRICS 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. BRICS 18F-FDG Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 252. G7 18F-FDG Market Size, by Group, 2017-2032 (USD Million)
TABLE 253. G7 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 254. G7 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 255. G7 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 256. G7 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-2032 (USD Million)
TABLE 257. G7 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 258. G7 18F-FDG Market Size, by Nucleophilic Fluorination, 2017-2032 (USD Million)
TABLE 259. G7 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 260. G7 18F-FDG Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 261. G7 18F-FDG Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 262. G7 18F-FDG Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 263. G7 18F-FDG Market Size, by Solid Tumors, 2017-2032 (USD Million)
TABLE 264. G7 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. G7 18F-FDG Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 266. NATO 18F-FDG Market Size, by Group, 2017-2032 (USD Million)
TABLE 267. NATO 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 268. NATO 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 269. NATO 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 270. NATO 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-2032 (USD Million)
TABLE 271. NATO 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 272. NATO 18F-FDG Market Size, by Nucleophilic Fluorination, 2017-2032 (USD Million)
TABLE 273. NATO 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 274. NATO 18F-FDG Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 275. NATO 18F-FDG Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 276. NATO 18F-FDG Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 277. NATO 18F-FDG Market Size, by Solid Tumors, 2017-2032 (USD Million)
TABLE 278. NATO 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. NATO 18F-FDG Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 280. Global 18F-FDG Market Size, by Country, 2017-2032 (USD Million)
TABLE 281. United States 18F-FDG Market Size, 2017-2032 (USD Million)
TABLE 282. United States 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 283. United States 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 284. United States 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 285. United States 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-2032 (USD Million)
TABLE 286. United States 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 287. United States 18F-FDG Market Size, by Nucleophilic Fluorination, 2017-2032 (USD Million)
TABLE 288. United States 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. United States 18F-FDG Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 290. United States 18F-FDG Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 291. United States 18F-FDG Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 292. United States 18F-FDG Market Size, by Solid Tumors, 2017-2032 (USD Million)
TABLE 293. United States 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 294. United States 18F-FDG Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 295. Canada 18F-FDG Market Size, 2017-2032 (USD Million)
TABLE 296. Canada 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 297. Canada 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 298. Canada 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 299. Canada 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-2032 (USD Million)
TABLE 300. Canada 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 301. Canada 18F-FDG Market Size, by Nucleophilic Fluorination, 2017-2032 (USD Million)
TABLE 302. Canada 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 303. Canada 18F-FDG Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 304. Canada 18F-FDG Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 305. Canada 18F-FDG Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 306. Canada 18F-FDG Market Size, by Solid Tumors, 2017-2032 (USD Million)
TABLE 307. Canada 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 308. Canada 18F-FDG Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 309. Mexico 18F-FDG Market Size, 2017-2032 (USD Million)
TABLE 310. Mexico 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 311. Mexico 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 312. Mexico 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 313. Mexico 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-2032 (USD Million)
TABLE 314. Mexico 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 315. Mexico 18F-FDG Market Size, by Nucleophilic Fluorination, 2017-2032 (USD Million)
TABLE 316. Mexico 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 317. Mexico 18F-FDG Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 318. Mexico 18F-FDG Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 319. Mexico 18F-FDG Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 320. Mexico 18F-FDG Market Size, by Solid Tumors, 2017-2032 (USD Million)
TABLE 321. Mexico 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 322. Mexico 18F-FDG Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 323. Brazil 18F-FDG Market Size, 2017-2032 (USD Million)
TABLE 324. Brazil 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 325. Brazil 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 326. Brazil 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 327. Brazil 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-2032 (USD Million)
TABLE 328. Brazil 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 329. Brazil 18F-FDG Market Size, by Nucleophilic Fluorination, 2017-2032 (USD Million)
TABLE 330. Brazil 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 331. Brazil 18F-FDG Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 332. Brazil 18F-FDG Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 333. Brazil 18F-FDG Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 334. Brazil 18F-FDG Market Size, by Solid Tumors, 2017-2032 (USD Million)
TABLE 335. Brazil 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 336. Brazil 18F-FDG Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 337. United Kingdom 18F-FDG Market Size, 2017-2032 (USD Million)
TABLE 338. United Kingdom 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 339. United Kingdom 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 340. United Kingdom 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 341. United Kingdom 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-2032 (USD Million)
TABLE 342. United Kingdom 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 343. United Kingdom 18F-FDG Market Size, by Nucleophilic Fluorination, 2017-2032 (USD Million)
TABLE 344. United Kingdom 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 345. United Kingdom 18F-FDG Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 346. United Kingdom 18F-FDG Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 347. United Kingdom 18F-FDG Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 348. United Kingdom 18F-FDG Market Size, by Solid Tumors, 2017-2032 (USD Million)
TABLE 349. United Kingdom 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 350. United Kingdom 18F-FDG Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 351. Germany 18F-FDG Market Size, 2017-2032 (USD Million)
TABLE 352. Germany 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 353. Germany 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 354. Germany 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 355. Germany 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-2032 (USD Million)
TABLE 356. Germany 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 357. Germany 18F-FDG Market Size, by Nucleophilic Fluorination, 2017-2032 (USD Million)
TABLE 358. Germany 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 359. Germany 18F-FDG Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 360. Germany 18F-FDG Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 361. Germany 18F-FDG Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 362. Germany 18F-FDG Market Size, by Solid Tumors, 2017-2032 (USD Million)
TABLE 363. Germany 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 364. Germany 18F-FDG Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 365. France 18F-FDG Market Size, 2017-2032 (USD Million)
TABLE 366. France 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 367. France 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 368. France 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 369. France 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-2032 (USD Million)
TABLE 370. France 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 371. France 18F-FDG Market Size, by Nucleophilic Fluorination, 2017-2032 (USD Million)
TABLE 372. France 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 373. France 18F-FDG Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 374. France 18F-FDG Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 375. France 18F-FDG Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 376. France 18F-FDG Market Size, by Solid Tumors, 2017-2032 (USD Million)
TABLE 377. France 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 378. France 18F-FDG Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 379. Russia 18F-FDG Market Size, 2017-2032 (USD Million)
TABLE 380. Russia 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 381. Russia 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 382. Russia 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 383. Russia 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-2032 (USD Million)
TABLE 384. Russia 18F-FDG Market Size, by Synthesis Process, 2017-2032 (USD Million)
TABLE 385. Russia 18F-FDG Market Size, by Nucleophilic Fluorination, 2017-2032 (USD Million)
TABLE 386. Russia 18F-FDG Market Size, by Application, 2017-2032 (USD Million)
TABLE 387. Russia 18F-FDG Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 388. Russia 18F-FDG Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 389. Russia 18F-FDG Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 390. Russia 18F-FDG Market Size, by Solid Tumors, 2017-2032 (USD Million)
TABLE 391. Russia 18F-FDG Market Size, by End User, 2017-2032 (USD Million)
TABLE 392. Russia 18F-FDG Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 393. Italy 18F-FDG Market Size, 2017-2032 (USD Million)
TABLE 394. Italy 18F-FDG Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 395. Italy 18F-FDG Market Size, by Research Grade, 2017-2032 (USD Million)
TABLE 396. Italy 18F-FDG Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 397. Italy 18F-FDG Market Size, by Sterile Aqueous Solution, 2017-20

Companies Mentioned

  • Advanced Accelerator Applications S.A.
  • Blue Earth Diagnostics Ltd.
  • Cardinal Health, Inc.
  • China Isotope & Radiation Corporation
  • Curium Pharma
  • DuChemBio Co., Ltd.
  • Eckert & Ziegler AG
  • GE HealthCare Technologies Inc.
  • Jubilant Pharmova Limited
  • Lantheus Holdings, Inc.
  • Life Molecular Imaging
  • Nihon Medi-Physics Co., Ltd.
  • PETNET Solutions, Inc.
  • PharmaLogic Holdings Corp.
  • Siemens Healthineers AG
  • Yantai Dongcheng Pharmaceutical Group Co., Ltd.

Related Reports

Fluorodeoxyglucose Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Fluorodeoxyglucose Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
PET Radiotracer - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

PET Radiotracer - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
South America Nuclear Imaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

South America Nuclear Imaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 90 Pages
From
Plasmacytoma Pipeline Analysis Report 2026 - Product Image

Plasmacytoma Pipeline Analysis Report 2026

  • Report
  • 200 Pages
  • Global
From
Novel PET Imaging Techniques in the Management of Hematologic Malignancies, An Issue of PET Clinics. The Clinics: Radiology Volume 19-4 - Product Image

Novel PET Imaging Techniques in the Management of Hematologic Malignancies, An Issue of PET Clinics. The Clinics: Radiology Volume 19-4

  • Book
Copyright © 2002-2026 Research and Markets. All Rights Reserved.